Quenet Torrent Institute: an R&D-intensive SME

Quenet Torrent Institute has obtained official recognition as an R&D-intensive SME for its research activity in oncology.

What being an R&D-intensive SME means

Official recognition for companies that devote >10% of their resources to research and development.

• Optimised HIPEC: Improved intraperitoneal chemotherapy protocols

• Prognostic biomarkers: Identifying the patients who benefit most

• Image-guided surgery: Intraoperative fluorescence, augmented reality. See augmented reality in surgery

• Perioperative immunonutrition: Optimising recovery

• Personalised therapies: Based on the molecular profile of the tumour

• >50 publications in international scientific journals

• Collaboration with centres in other countries (MD Anderson, Gustave Roussy, etc.)

• Participation in multicentre clinical trials

• Training of oncological surgeons from all over Europe

Access to:

• New treatments before they become widely available

• Clinical trials with experimental therapies

• A team that keeps up to date with recent research

• Protocols based on our own research

Interested in taking part in clinical trials? Ask about the availability of active studies. More information.